Meta analysis compares early and delayed DOAC resumption after ischemic stroke in AF patients, suggesting optimal timing remains uncertain.
Background: For patients with atrial fibrillation (AF) who experience acute ischemic stroke, clinicians must balance prevention of early recurrent embolism against the risk of intracranial hemorrhage (ICH) when restarting direct oral anticoagulants (DOACs). The optimal timing for DOAC resumption remains uncertain.
No takes yet. Share an insight, caveat, or question.
Ahmed Nawsher Alam (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: